Table 2:

Clinical outcomes at 1-year follow-up

Population (n = 48)ACOPCO
mRS 0–1 (%)25 (52.1)17/34 (50.0)8/14 (57.1)
mRS 0–2 (%)30 (62.5)22/34 (64.7)8/14 (57.1)
mRS 3 (%)3 (6.2)2/34 (5.9)1/14 (7.1)
mRS 4–5 (%)7 (14.6)6/34 (17.6)1/14 (7.1)
mRS 6 (mortality) (%)8/48 (16.7)4/34 (11.8)4/14 (28.6)
SF-36 PCS (mean) (median, range)51.2 (52.8, 5.6–100)49.9 (51.9, 5.6–100)56.3 (60.6, 32.9–71.0)
SF-36 MCS (mean) (median, range)51.4 (47.1, 4.0–98.8)50.4 (47.1, 4.0–98.8)53.9 (48.6, 32.3–81.1)